Cargando…
Delivering bioactive cyclic peptides that target Hsp90 as prodrugs
The most challenging issue facing peptide drug development is producing a molecule with optimal physical properties while maintaining target binding affinity. Masking peptides with protecting groups that can be removed inside the cell, produces a cell-permeable peptide, which theoretically can maint...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407599/ https://www.ncbi.nlm.nih.gov/pubmed/30822267 http://dx.doi.org/10.1080/14756366.2019.1580276 |